Enlicitide, an oral cholesterol-lowering drug, is catching attention among doctors as an option for patients who want an injection-free treatment. Merck has also reached a milestone in its cholesterol drug pipeline, while a cholesterol medicine backed by McMaster University science has received approval in Canada.

Health outlets this week reported on how exercise changes LDL cholesterol readings, and TODAY.com cautioned readers against following cholesterol advice shared across social media platforms. LDL cholesterol is often called the 'bad' type because raised levels increase the risk of heart disease.